Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2025)

Rocket Pharmaceuticals' Other Operating Expenses history spans 5 years, with the latest figure at -$172000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to -$172000.0; the TTM value through Dec 2025 reached $99000.0, changed N/A, while the annual FY2018 figure was -$78.2 million, 118.81% down from the prior year.
  • Other Operating Expenses for Q3 2025 was -$172000.0 at Rocket Pharmaceuticals, down from $271000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $271000.0 in Q2 2025 and bottomed at -$172000.0 in Q3 2025.